Menter, A. M., Draelos, Z., Heim, J., Gogineni, R., & Griffiths, C. E. (2023). Efficacy and safety by body weight decile in patients treated with tildrakizumab 100 mg for 28 weeks: Pooled data analysis of reSURFACE 1 and reSURFACE 2. SKIN The Journal of Cutaneous Medicine, 7(2), s136. https://doi.org/10.25251/skin.7.supp.136